NOT FOR DISTRIBUTION
Header cover image

Market Cap

JP¥4.8t

Last Updated

2021/05/15 08:24 UTC

Data Sources

Company Financials +

Executive Summary

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. More Details

Rewards

Earnings are forecast to grow 10.94% per year

Earnings grew by 9.7% over the past year

Risk Analysis

No risks detected for 7741 from our risk checks.


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has HOYA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 7741 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 7741's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

-0.8%

7741

-4.9%

JP Medical Equipment

-2.5%

JP Market


1 Year Return

34.7%

7741

17.3%

JP Medical Equipment

28.6%

JP Market

Return vs Industry: 7741 exceeded the JP Medical Equipment industry which returned 17.3% over the past year.

Return vs Market: 7741 exceeded the JP Market which returned 28.6% over the past year.


Shareholder returns

7741IndustryMarket
7 Day-0.8%-4.9%-2.5%
30 Day-4.0%-5.2%-3.9%
90 Day-0.2%-7.0%-3.1%
1 Year35.7%34.7%18.4%17.3%31.4%28.6%
3 Year108.6%102.5%29.2%25.8%11.1%3.4%
5 Year258.9%238.5%66.3%59.2%54.9%37.9%

Long-Term Price Volatility Vs. Market

How volatile is HOYA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is HOYA undervalued compared to its fair value and its price relative to the market?

38.82x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 7741 (¥13035) is trading above our estimate of fair value (¥9913.09)

Significantly Below Fair Value: 7741 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 7741 is poor value based on its PE Ratio (38.8x) compared to the JP Medical Equipment industry average (21.9x).

PE vs Market: 7741 is poor value based on its PE Ratio (38.8x) compared to the JP market (16.2x).


Price to Earnings Growth Ratio

PEG Ratio: 7741 is poor value based on its PEG Ratio (3.5x)


Price to Book Ratio

PB vs Industry: 7741 is overvalued based on its PB Ratio (7x) compared to the JP Medical Equipment industry average (2.1x).


Future Growth

How is HOYA forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

10.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7741's forecast earnings growth (10.9% per year) is above the savings rate (0%).

Earnings vs Market: 7741's earnings (10.9% per year) are forecast to grow slower than the JP market (14.3% per year).

High Growth Earnings: 7741's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7741's revenue (7.1% per year) is forecast to grow faster than the JP market (5.4% per year).

High Growth Revenue: 7741's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7741's Return on Equity is forecast to be high in 3 years time (24.2%)


Past Performance

How has HOYA performed over the past 5 years?

7.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 7741 has high quality earnings.

Growing Profit Margin: 7741's current net profit margins (22.9%) are higher than last year (19.8%).


Past Earnings Growth Analysis

Earnings Trend: 7741's earnings have grown by 7.2% per year over the past 5 years.

Accelerating Growth: 7741's earnings growth over the past year (9.7%) exceeds its 5-year average (7.2% per year).

Earnings vs Industry: 7741 earnings growth over the past year (9.7%) exceeded the Medical Equipment industry 4.1%.


Return on Equity

High ROE: 7741's Return on Equity (18.6%) is considered low.


Financial Health

How is HOYA's financial position?


Financial Position Analysis

Short Term Liabilities: 7741's short term assets (¥554.6B) exceed its short term liabilities (¥131.6B).

Long Term Liabilities: 7741's short term assets (¥554.6B) exceed its long term liabilities (¥49.3B).


Debt to Equity History and Analysis

Debt Level: 7741 is debt free.

Reducing Debt: 7741 has no debt compared to 5 years ago when its debt to equity ratio was 7.4%.

Debt Coverage: 7741 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 7741 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is HOYA current dividend yield, its reliability and sustainability?

0.69%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 7741's dividend (0.69%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.29%).

High Dividend: 7741's dividend (0.69%) is low compared to the top 25% of dividend payers in the JP market (2.94%).


Stability and Growth of Payments

Stable Dividend: 7741 is not paying a notable dividend for the JP market, therefore no need to check if payments are stable.

Growing Dividend: 7741 is not paying a notable dividend for the JP market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 7741 is not paying a notable dividend for the JP market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 7741's dividend in 3 years as they are not forecast to pay a notable one for the JP market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.9yrs

Average board tenure


CEO

Hiroshi Suzuki (62 yo)

17.92yrs

Tenure

JP¥168,000,000

Compensation

Mr. Hiroshi Suzuki has been the Chief Executive Officer of HOYA Corporation since June 2003 and has been its President since June 2000. Mr. Suzuki serves as Representative Executive Officer at HOYA Corpora...


CEO Compensation Analysis

Compensation vs Market: Hiroshi's total compensation ($USD1.54M) is about average for companies of similar size in the JP market ($USD1.83M).

Compensation vs Earnings: Hiroshi's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: 7741's board of directors are considered experienced (5.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

HOYA Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: HOYA Corporation
  • Ticker: 7741
  • Exchange: TSE
  • Founded: 1941
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: JP¥4.819t
  • Shares outstanding: 369.70m
  • Website: https://www.hoya.co.jp

Number of Employees


Location

  • HOYA Corporation
  • Nittochi Nishishinjuku Building
  • 20th Floor
  • Tokyo
  • 160-8347
  • Japan

Listings


Biography

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The L...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/15 08:24
End of Day Share Price2021/05/14 00:00
Earnings2021/03/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.